ARTLClinical Trials•globenewswire•
Artelo Biosciences Announces New Data from an Initial Food Effect Investigation with ART26.12, a Novel Non-Opioid Treatment Candidate for Persistent Pain
Sentiment:Positive (65)
Summary
Safety and Pharmacokinetic Data Support Dosing of ART26.12 in Fed or Fasted Conditions
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by globenewswire